T. Rowe Price Associates’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-730,864
| Closed | -$7.29M | – | 3029 |
|
|
2021
Q4 | $7.29M | Hold |
730,864
| – | – | ﹤0.01% | 1455 |
|
|
2021
Q3 | $7.28M | Hold |
730,864
| – | – | ﹤0.01% | 1466 |
|
|
2021
Q2 | $7.45M | Sell |
730,864
-56,026
| -7% | -$571K | ﹤0.01% | 1450 |
|
|
2021
Q1 | $7.94M | Buy |
786,890
+20,300
| +3% | +$205K | ﹤0.01% | 1422 |
|
|
2020
Q4 | $8.17M | Buy |
+766,590
| New | +$8.17M | ﹤0.01% | 1374 |
|